SEC, US Trustee Object To Releases In Amyris' Ch. 11 Plan
The U.S. Securities and Exchange Commission and the U.S. Trustee's Office have expressed new concerns about nonconsensual third-party releases in biotechnology company Amyris' Chapter 11 plan, arguing that such releases are...To view the full article, register now.
Already a subscriber? Click here to view full article